Intraoral dosage forms of glucagon
    3.
    发明授权
    Intraoral dosage forms of glucagon 有权
    胰高血糖素的口服剂型

    公开(公告)号:US08975227B2

    公开(公告)日:2015-03-10

    申请号:US11994032

    申请日:2006-07-17

    IPC分类号: A61K38/26 C07K14/605

    CPC分类号: A61K38/26 C07K14/605

    摘要: The present invention provides a composition (e.g., a pharmaceutical composition) comprising at least one delivery agent compound and glucagon. Preferably, the composition includes a therapeutically effective amount of glucagon and the delivery agent compound. The composition of the present invention facilitates the delivery of glucagon and increases its bioavailability compared to administration without the delivery agent compound.

    摘要翻译: 本发明提供包含至少一种递送剂化合物和胰高血糖素的组合物(例如,药物组合物)。 优选地,组合物包含治疗有效量的胰高血糖素和递送剂化合物。 本发明的组合物有助于胰高血糖素的递送,并且与不含递送剂化合物的给药相比,其生物利​​用度增加。

    Intraoral Dosage Forms of Glucagon
    4.
    发明申请
    Intraoral Dosage Forms of Glucagon 有权
    胰高血糖素的口服剂量形式

    公开(公告)号:US20080207514A1

    公开(公告)日:2008-08-28

    申请号:US11994032

    申请日:2006-07-17

    IPC分类号: A61K38/26 A61P3/10

    CPC分类号: A61K38/26 C07K14/605

    摘要: The present invention provides a composition (e.g., a pharmaceutical composition) comprising at least one delivery agent compound and glucagon. Preferably, the composition includes a therapeutically effective amount of glucagon and the delivery agent compound. The composition of the present invention facilitates the delivery of glucagon and increases its bioavailability compared to administration without the delivery agent compound.

    摘要翻译: 本发明提供包含至少一种递送剂化合物和胰高血糖素的组合物(例如药物组合物)。 优选地,组合物包含治疗有效量的胰高血糖素和递送剂化合物。 本发明的组合物有助于胰高血糖素的递送,并且与不含递送剂化合物的给药相比,其生物利​​用度增加。